Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Repligen Corp shares valued at $3,271,688 were sold by Hunt Anthony on May 15 ’25. At $123.71 per share, Hunt Anthony sold 26,447 shares. The insider’s holdings dropped to 109,854 shares worth approximately $12.47 million following the completion of this transaction.
Also, Hunt Anthony purchased 26,447 shares, netting a total of over 3,394,208 in proceeds.
Before that, Hunt Anthony had sold 26,756 shares from its account. In a trade valued at $4,080,663, the Director traded Repligen Corp shares for $152.51 each. Upon closing the transaction, the insider’s holdings decreased to 26,756 shares, worth approximately $15.47 million.
Analysts at Barclays started covering the stock with ‘”an Overweight”‘ outlook in a report released in late June. As of April 29, 2025, Wolfe Research has increased its “Peer perform” rating to a “an Outperform” for RGEN. Earlier on March 18, 2025, Evercore ISI initiated its rating. Their recommendation was “an In-line” for RGEN stock.
Analyzing RGEN Stock Performance
On last trading session, Repligen Corp [NASDAQ: RGEN] rose 1.27% to $113.52. The stock’s lowest price that day was $111.36, but it reached a high of $113.58 in the same session. During the last five days, there has been a drop of approximately -3.03%. Over the course of the year, Repligen Corp shares have dropped approximately -30.01%.
Is Repligen Corp subject to short interest?
Stocks of Repligen Corp saw a sharp rise in short interest on 2025-07-15 jumping by 7266.0 shares to 3.4 million. Data from Yahoo Finance shows that the short interest on 2025-06-13 was 3.39 million shares. A jump of 0.21% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 4.65 of the overall float, the days-to-cover ratio (short ratio) jumped to 4.65.
Which companies own the most shares of Repligen Corp (RGEN)?
In terms of Repligen Corp share price expectations, FactSet research, analysts set an average price target of 200 in the next 12 months, up nearly 78.41% from the previous closing price of $112.1. Analysts anticipate Repligen Corp stock to reach 220 by 2025, with the lowest price target being 155. In spite of this, 9 analysts ranked Repligen Corp stock as Buy at the end of 2025. On February 10, 2025, TD Cowen assigned a price target of “a Buy” to the stock and initiated coverage with a $200.
